ISRCTN15331714进行中（未招募）未知
Stratifying risk for early detection in hereditary breast and ovarian cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 600
研究概览
简要总结
2022 Protocol article in https://doi.org/10.3390/cancers14112716 (added 21/06/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •2. Age >18 years
- •3. Undergoing predictive testing for a PV in BRCA1, BRCA2, PALB2, ATM or CHEK2
- •4. Able to give informed consent
排除标准
- •Previous history of breast cancer or ovarian cancer
研究者
相似试验
尚未招募
不适用
Detection of familial cancer risk in Indian men with prostate cancer.CTRI/2021/01/030180AIIMS Intramural Fund
尚未招募
3 期
The genetic screening to the hereditariness breast cancer high risk groupThe hereditariness breast cancer high risk groupJPRN-UMIN000013763Department of Breast Disease Center, Asahikawa Medical University100
已完成
不适用
A Registry for Hereditary Cancer Risk Assessment and Genetic TestingProstate CancerNCT04015102Myriad Genetic Laboratories, Inc.255
尚未招募
不适用
ational Cancer Institute Cancer Awareness Risk assessment and Early detection of Prostate Oral Head Neck CancersCTRI/2022/11/047056Bayer Pharmaceuticals Pvt Ltd
进行中（未招募）
不适用
Cell-free DNA in Hereditary And High-Risk Malignancies 1Hereditary Cancer SyndromeNCT04261972University Health Network, Toronto1,416